S
Susan M. Wolf
Researcher at University of Minnesota
Publications - 186
Citations - 8076
Susan M. Wolf is an academic researcher from University of Minnesota. The author has contributed to research in topics: Return of results & Health care. The author has an hindex of 39, co-authored 184 publications receiving 7526 citations. Previous affiliations of Susan M. Wolf include Wake Forest University & Law School Admission Council.
Papers
More filters
Journal ArticleDOI
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Michael L. Etheridge,Stephen A. Campbell,Arthur G. Erdman,Christy L. Haynes,Susan M. Wolf,Jeffrey McCullough +5 more
TL;DR: The state of nanomedicine commercialization is discussed, concentrating only on nanomediine-based developments and products that are either in clinical trials or have already been approved for use.
Journal ArticleDOI
Managing incidental findings in human subjects research: Analysis and recommendations
Susan M. Wolf,Frances P Lawrenz,Charles A. Nelson,Jeffrey P. Kahn,Mildred K. Cho,Ellen Wright Clayton,Joel G. Fletcher,Michael K. Georgieff,Dale E. Hammerschmidt,Kathy Hudson,Judy Illes,Vivek Kapur,Moira A. Keane,Barbara A. Koenig,Bonnie S. LeRoy,Elizabeth G. McFarland,Jordan Paradise,Lisa S. Parker,Sharon F. Terry,Brian G Van Ness,Benjamin S. Wilfond +20 more
TL;DR: Recommendations of a two-year project group funded by NIH to study how to manageIFs in genetic and genomic research, as well as imaging research are reported, which conclude that researchers have an obligation to address the possibility of discovering IFs in their protocol and communications with the IRB and research participants.
Journal ArticleDOI
Decisions near the end of life: professional views on life-sustaining treatments.
Mildred Z. Solomon,Lydia O'Donnell,Bruce Jennings,Vivian Guilfoy,Susan M. Wolf,Kathleen Nolan,Rebecca Jackson,Dieter Koch-Weser,Strachan Donnelley +8 more
TL;DR: Many physicians and nurses were disturbed by the degree to which technological solutions influence care during the final days of a terminal illness and by the undertreatment of pain.
Journal ArticleDOI
Managing incidental findings and research results in genomic research involving biobanks and archived data sets.
Susan M. Wolf,Brittney N. Crock,Brian G Van Ness,Frances P Lawrenz,Jeffrey P. Kahn,Laura M. Beskow,Mildred K. Cho,Michael F. Christman,Robert C. Green,Ralph F. Hall,Judy Illes,Moira A. Keane,Bartha Maria Knoppers,Barbara A. Koenig,Isaac S. Kohane,Bonnie S. LeRoy,Karen J. Maschke,William McGeveran,Pilar N. Ossorio,Lisa S. Parker,Gloria M. Petersen,Henry S. Richardson,Joan Scott,Sharon F. Terry,Benjamin S. Wilfond,Wendy A. Wolf +25 more
TL;DR: It is suggested that findings that are analytically valid, reveal an established and substantial risk of a serious health condition, and are clinically actionable should generally be offered to consenting contributors.
Journal ArticleDOI
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between
Gail P. Jarvik,Laura M. Amendola,Jonathan S. Berg,Ellen Wright Clayton,Wendy K. Chung,Barbara J. Evans,James P. Evans,Stephanie M. Fullerton,Carlos J. Gallego,Nanibaa’ A. Garrison,Stacy W. Gray,Ingrid A. Holm,Iftikhar J. Kullo,Lisa Soleymani Lehmann,Catherine A. McCarty,Cynthia A. Prows,Heidi L. Rehm,Richard R. Sharp,Joseph Salama,Saskia C. Sanderson,Sara L. Van Driest,Marc S. Williams,Susan M. Wolf,Wendy A. Wolf,Wylie Burke +24 more
TL;DR: Research investigators should be prepared to return research results and incidental findings discovered in the course of their research and meeting an actionability threshold, but they have no ethical obligation to actively search for such results.